BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8455018)

  • 21. Green tea extract impedes dyslipidaemia and development of cardiac dysfunction in streptozotocin-diabetic rats.
    Anandh Babu PV; Sabitha KE; Shyamaladevi CS
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1184-9. PubMed ID: 17184499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
    Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
    Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.
    Yao J; Battell ML; McNeill JH
    Can J Physiol Pharmacol; 1997 Feb; 75(2):83-90. PubMed ID: 9114928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoic acid acutely induces hypoglycemia in fasting nondiabetic and diabetic rats.
    Khamaisi M; Rudich A; Potashnik R; Tritschler HJ; Gutman A; Bashan N
    Metabolism; 1999 Apr; 48(4):504-10. PubMed ID: 10206446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of phlorizin and acipimox on insulin resistance in STZ-diabetic rats.
    Kim YW; Kim JY; Lee SK
    J Korean Med Sci; 1995 Feb; 10(1):24-30. PubMed ID: 7598820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical studies on the effect of S-1,3-butanediol of diabetes induced rats.
    Meenakshi C; Kumari KL; Devi CS
    Indian J Physiol Pharmacol; 1995 Apr; 39(2):145-8. PubMed ID: 7649603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lowering of plasma glucose in diabetic rats by antilipolytic agents.
    Reaven GM; Chang H; Ho H; Jeng CY; Hoffman BB
    Am J Physiol; 1988 Jan; 254(1 Pt 1):E23-30. PubMed ID: 2962514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic effects of the glucose tolerance factor (GTF) in normal and genetically diabetic mice.
    Tuman RW; Doisy RJ
    Diabetes; 1977 Sep; 26(9):820-6. PubMed ID: 892235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
    Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
    Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of combined insulin and somatostatin infusion for the treatment of experimental diabetic ketoacidosis.
    Harano Y; Ohgaku S; Hidaka H; Takatsuki K; Shigeta Y
    Horm Metab Res; 1979 May; 11(5):338-42. PubMed ID: 113327
    [No Abstract]   [Full Text] [Related]  

  • 31. Correlation between the antilipolytic and hypoglycemic actions of some salicylate structural congeners in normal and alloxan-diabetic rats.
    Fang VS
    Arch Int Pharmacodyn Ther; 1969 Apr; 178(2):315-23. PubMed ID: 5355562
    [No Abstract]   [Full Text] [Related]  

  • 32. Antihyperlipidemic effect of D-pinitol on streptozotocin-induced diabetic Wistar rats.
    Geethan PK; Prince PS
    J Biochem Mol Toxicol; 2008; 22(4):220-4. PubMed ID: 18752266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoglycemic effect and mechanism of a proteoglycan from ganoderma lucidum on streptozotocin-induced type 2 diabetic rats.
    Teng BS; Wang CD; Zhang D; Wu JS; Pan D; Pan LF; Yang HJ; Zhou P
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):166-75. PubMed ID: 22428467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of the glucose lowering effect of a carnitine palmitoyl transferase inhibitor in normal and diabetic rats.
    Martin C; Odeon M; Cohen R; Beylot M
    Metabolism; 1991 Apr; 40(4):420-7. PubMed ID: 2011084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of nicotinic acid on growth hormone-induced lipolysis and glucose intolerance.
    Davidson MB; Bernstein JM
    J Lab Clin Med; 1973 Apr; 81(4):568-76. PubMed ID: 4696189
    [No Abstract]   [Full Text] [Related]  

  • 36. Beneficial effects of aloe vera leaf gel extract on lipid profile status in rats with streptozotocin diabetes.
    Rajasekaran S; Ravi K; Sivagnanam K; Subramanian S
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):232-7. PubMed ID: 16487267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
    Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
    Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. So many choices, so what's a consumer to do?: A commentary on "Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats".
    Vinson JA
    Free Radic Biol Med; 2007 Oct; 43(8):1121-3. PubMed ID: 17854707
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of exercise training on glucose homeostasis in normal and insulin-deficient diabetic rats.
    Goodyear LJ; Hirshman MF; Knutson SM; Horton ED; Horton ES
    J Appl Physiol (1985); 1988 Aug; 65(2):844-51. PubMed ID: 3049514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on the mechanism of the diabetogenic activity of streptozotocin and on the ability of compounds to block the diabetogenic activity of streptozotocin (author's transl)].
    Doi K
    Nihon Naibunpi Gakkai Zasshi; 1975 Mar; 51(3):129-47. PubMed ID: 169168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.